🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for RUNX1 Familial Platelet Disorder

Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder NCT07844694Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Questionnaire Administration, Sirolimus Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TruSight Oncology, imatinib Longitudinal Studies of Patient With FPDMM NCT03854318n/a1 site📍 Bethesda National Human Genome Research Institute (NHGRI) Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder NCT06261060Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Sirolimus Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder NCT06414889Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: G-CSF (filgrastim or biosimilar), Apheresis, Plerixafor
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy